Digital Technology and Mobile Health in Behavioral Migraine Therapy: a Narrative Review
Overview
Authors
Affiliations
Purpose Of Review: This article reviews the recent research and development of electronic health (eHealth) and, in particular, mobile health (mHealth) strategies to deliver behavioral treatment for migraine. Prospects for future development and research of mobile health in migraine are suggested.
Recent Findings: Advances in digital technology and mobile technology have led to an era where electronic and mobile approaches are applied to several aspects of healthcare. Electronic behavioral interventions for migraine seem to be acceptable and feasible, but efficacy measures are uncertain. Clinical trials on mHealth-based classical behavioral therapies, such as relaxation, biofeedback, and cognitive behavioral therapy are missing in the literature. Within mHealth, headache diaries are the most researched and scientifically developed. Still, there is a gap between commercially available apps and scientifically validated and developed apps. Digital technology and mobile health has not yet lived out its potential in behavioral migraine therapy. Application of proper usability and functionality designs towards the right market, together with appraisal of medical and technological recommendations, may facilitate rapid development of eHealth and mHealth, while also establishing scientific evidence.
Petrusic I, Ha W, Labastida-Ramirez A, Messina R, Onan D, Tana C J Headache Pain. 2024; 25(1):151.
PMID: 39272003 PMC: 11401391. DOI: 10.1186/s10194-024-01847-7.
Minen M, George A, Lebowitz N, Katara A, Snyder I Front Neurol. 2024; 14:1270555.
PMID: 38322798 PMC: 10844531. DOI: 10.3389/fneur.2023.1270555.
Ulrich S, Gantenbein A, Zuber V, von Wyl A, Kowatsch T, Kunzli H J Med Internet Res. 2024; 26:e50132.
PMID: 38265863 PMC: 10851123. DOI: 10.2196/50132.
Huguet A, Rozario S, Wozney L, McGrath P JMIR Hum Factors. 2023; 10:e48677.
PMID: 38085567 PMC: 10751633. DOI: 10.2196/48677.
Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era.
Chen X, Luo Y J Pain Res. 2023; 16:111-117.
PMID: 36660558 PMC: 9842514. DOI: 10.2147/JPR.S387548.